Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin
<p>Abstract</p> <p>Background</p> <p>Platinum-containing chemotherapy produces specific DNA damage and is used to treat several human solid tumors. Tumors initially sensitive to platinum-based drugs frequently become resistant. Inhibition of DNA repair is a potential st...
Main Authors: | Calkins Anne S, Sobhian Bijan, Adelmant Guillaume, Sand-Dejmek Janna, Marto Jarrod, Iglehart Dirk J, Lazaro Jean-Bernard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/74 |
Similar Items
-
PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin
by: Daniele Musiani, et al.
Published: (2020-01-01) -
The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
by: Jinhua Quan, et al.
Published: (2014-01-01) -
The Role of DNA Repair Complex DNA-PK in HIV-1 Transcription
by: Olga Shadrina, et al.
Published: (2020-07-01) -
Small molecules, inhibitors of DNA-PK, targeting DNA repair and beyond
by: David eDavidson, et al.
Published: (2013-01-01) -
Pyridopyrimidinone and quinolinone inhibitors of DNA-dependent protein kinase (DNA-PK)
by: Barbeau, Olivier R.
Published: (2005)